Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
QL-415 by QLSF Biotherapeutics for Hematological Tumor: Likelihood of Approval
QL-415 is under clinical development by QLSF Biotherapeutics and currently in Phase I for Hematological Tumor. According to GlobalData, Phase...